secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2024-04-18T23:59:59+00:00
Accession:  0001493152-24-015198
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INBS preliminary Q3 revenue $0.82M, up 80% YoY; nine-month revenue $2.38M, up 193%
--------------------------------------------------------------------------------

- Preliminary unaudited revenue $0.82M for fiscal Q3 ended March 31, 2024, up 80% vs. prior year.
- Nine-month revenue $2.38M, up 193% YoY.
- Cartridge sales up 17% and reader sales up 20% in Q3; highest quarterly cartridge sales since 2022 acquisition.
- Nine-month cartridge sales up 25%, reader sales up 63% YoY.
- Full financial results expected in Form 10-Q filed during week of May 6, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315224015198/0001493152-24-015198-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315224015198/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-015198

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer